Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' DOSTERT P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 68 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Maruyama, W; Boulton, AA; Davis, BA; Dostert, P; Naoi, M
      Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells: suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine

      JOURNAL OF NEURAL TRANSMISSION
    2. Breda, M; Benedetti, MS; Battaglia, R; Castelli, MG; Poggesi, I; Spinelli, R; Hackett, AM; Dostert, P
      Species-differences in disposition and reductive metabolism of methoxymorpholinodoxorubicin (PNU 152243), a new potential anticancer agent

      PHARMACOLOGICAL RESEARCH
    3. Maruyama, W; Sango, K; Iwasa, K; Minami, C; Dostert, P; Kawai, M; Moriyasu, M; Naoi, M
      Dopaminergic neurotoxins, 6,7-dihydroxy-1-(3 ',4 '-dihydroxybenzyl)-isoquinolines, cause different types of cell death in SH-SY5Y cells: apoptosis was induced by oxidized papaverolines and necrosis by reduced tetrahydropapaverolines

      NEUROSCIENCE LETTERS
    4. Sango, K; Maruyama, W; Matsubara, K; Dostert, P; Minami, C; Kawai, M; Naoi, M
      Enantio-selective occurrence of (S)-tetrahydropapaveroline in human brain

      NEUROSCIENCE LETTERS
    5. Rey, E; Dostert, P; d'Athis, P; Jannuzzo, MG; Poggesi, I; Olive, G
      Dose proportionality of reboxetine enantiomers in healthy male volunteers

      BIOPHARMACEUTICS & DRUG DISPOSITION
    6. Reinach, B; de Sousa, G; Dostert, P; Ings, R; Gugenheim, J; Rahmani, R
      Comparative effects of rifabutin and rifampicin on cytochromes P450 and UDP-glucuronosyl-transferases expression in fresh and cryopreserved human hepatocytes

      CHEMICO-BIOLOGICAL INTERACTIONS
    7. ALLIEVI C; DOSTERT P
      QUANTITATIVE-DETERMINATION OF CABERGOLINE IN HUMAN PLASMA USING LIQUID-CHROMATOGRAPHY COMBINED WITH TANDEM MASS-SPECTROMETRY

      Rapid communications in mass spectrometry
    8. NAOI M; MARUYAMA W; KASAMATSU T; DOSTERT P
      OXIDATION OF N-METHYL(R)SALSOLINOL - INVOLVEMENT TO NEUROTOXICITY ANDNEUROPROTECTION BY ENDOGENOUS CATECHOL ISOQUINOLINES

      Journal of neural transmission. Supplementum
    9. MORIKAWA N; NAOI M; MARUYAMA W; OHTA S; KOTAKE Y; KAWAI H; NIWA T; DOSTERT P; MIZUNO Y
      EFFECTS OF VARIOUS TETRAHYDROISOQUINOLINE DERIVATIVES ON MITOCHONDRIAL RESPIRATION AND THE ELECTRON-TRANSFER COMPLEXES

      Journal of neural transmission
    10. PEVARELLO P; BONSIGNORI A; DOSTERT P; HEIDEMPERGHER F; PINCIROLI V; COLOMBO M; MCARTHUR RA; SALVATI P; POST C; FARIELLO RG; VARASI M
      SYNTHESIS AND ANTICONVULSANT ACTIVITY OF A NEW CLASS OF 2-[(ARYLALKYL)AMINO]ALKANAMIDE DERIVATIVES

      Journal of medicinal chemistry
    11. DENG YL; MARUYAMA W; KAWAI M; DOSTERT P; YAMAMURA H; TAKAHASHI T; NAOI M
      ASSAY FOR THE (R)-ENANTIOMERS AND (S)-ENANTIOMERS OF SALSOLINOLS IN BIOLOGICAL SAMPLES AND FOODS WITH ION-PAIR HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY USING BETA-CYCLODEXTRIN AS A CHIRAL MOBILE-PHASE ADDITIVE

      Journal of chromatography B. Biomedical sciences and applications
    12. DOSTERT P; BENEDETTI MS; POGGESI I
      REVIEW OF THE PHARMACOKINETICS AND METABOLISM OF REBOXETINE, A SELECTIVE NORADRENALINE REUPTAKE INHIBITOR

      European neuropsychopharmacology
    13. FRIGERIO E; BENECCHI A; BRIANCESCHI G; PELLIZZONI C; POGGESI I; BENEDETTI MS; DOSTERT P
      PHARMACOKINETICS OF REBOXETINE ENANTIOMERS IN THE DOG

      Chirality
    14. BREDA M; SARATI S; BASILEO G; DOSTERT P
      ENANTIOSELECTIVE DETERMINATION OF FCE-28833, A NEW POTENTIAL ANTIISCHEMIC AGENT, IN GERBIL PLASMA USING COLUMN-SWITCHING HPLC WITH UV DETECTION

      Chirality
    15. ANGIULI P; FONTANA E; DOSTERT P
      SYNTHESIS OF [(17)-C-14] NICERGOLINE

      Journal of labelled compounds & radiopharmaceuticals
    16. MARUYAMA W; SOBUE G; MATSUBARA K; HASHIZUME Y; DOSTERT P; NAOI M
      A DOPAMINERGIC NEUROTOXIN, THYL-6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE, N-METHYL(R)SALSOLINOL, AND ITS OXIDATION-PRODUCT, 1,2(N)-DIMETHYL-6,7-DIHYDROXYISOQUINOLINIUM ION, ACCUMULATE IN THE NIGROSTRIATAL SYSTEM OF THE HUMAN BRAIN

      Neuroscience letters
    17. NAOI M; MARUYAMA W; DOSTERT P; HASHIZUME Y
      N-METHYL-(R)SALSOLINOL AS A DOPAMINERGIC NEUROTOXIN - FROM AN ANIMAL-MODEL TO AN EARLY MARKER OF PARKINSONS-DISEASE

      Journal of neural transmission. Supplementum
    18. TAKAHASHI T; MARUYAMA W; DENG Y; DOSTERT P; NAKAHARA D; NIWA T; OHTA S; NAOI M
      CYTOTOXICITY OF ENDOGENOUS ISOQUINOLINES TO HUMAN DOPAMINERGIC NEUROBLASTOMA SH-SY5Y CELLS

      Journal of neural transmission
    19. MARUYAMA W; NAOI M; KASAMATSU T; HASHIZUME Y; TAKAHASHI T; KOHDA K; DOSTERT P
      AN ENDOGENOUS DOPAMINERGIC NEUROTOXIN, N-METHYL-(R)-SALSOLINOL, INDUCES DNA-DAMAGE IN HUMAN DOPAMINERGIC NEUROBLASTOMA SH-SY5Y CELLS

      Journal of neurochemistry
    20. LACROIX R; DOSTERT P; BENEDETTI MS
      SENSITIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF 2-PHENYLETHYLAMINE IN HUMAN URINE

      Journal of chromatography B. Biomedical applications
    21. MARUYAMA W; ABE T; TOHGI H; DOSTERT P; NAOI M
      A DOPAMINERGIC NEUROTOXIN, (R)-N-METHYLSALSOLINOL, INCREASES IN PARKINSONIAN CEREBROSPINAL-FLUID

      Annals of neurology
    22. FONTANA E; ANGIULI P; PIGNATTI A; PANZERI A; DOSTERT P
      SYNTHESIS OF C-14-LABELED A-ANDROSTANE-17-BETA-CARBONYL]-1,3-DIISOPROPYLUREA (TUROSTERIDE), A NEW 5-ALPHA-REDUCTASE INHIBITOR

      Journal of labelled compounds & radiopharmaceuticals
    23. FONTANA E; GIRIBONE D; PIGNATTI A; GALANTINO M; FORINO R; DOSTERT P
      SYNTHESIS OF TRITIUM-LABELED THYMIC HUMORAL FACTOR GAMMA-2 (THF-GAMMA-2, THYMOCTONAN)

      Journal of labelled compounds & radiopharmaceuticals
    24. BOTTIGER Y; DOSTERT P; BENEDETTI MS; BANI M; FIORENTINI F; CASATI M; POGGESTI I; ALM C; ALVAN G; BERTILSSON L
      INVOLVEMENT OF CYP2D6 BUT NOT CYP2C19 IN NICERGOLINE METABOLISM IN HUMANS

      British journal of clinical pharmacology
    25. OESCH F; ARAND M; BENEDETTI MS; CASTELLI MG; DOSTERT P
      INDUCING PROPERTIES OF RIFAMPICIN AND RIFABUTIN FOR SELECTED ENZYME-ACTIVITIES OF THE CYTOCHROME-P-450 AND UDP-GLUCURONOSYLTRANSFERASE SUPERFAMILIES IN FEMALE RAT-LIVER

      Journal of antimicrobial chemotherapy
    26. NAOI M; MARUYAMA W; DOSTERT P; KOHDA K; KAIYA T
      A NOVEL ENZYME ENANTIO-SELECTIVELY SYNTHESIZES (R)SALSOLINOL, A PRECURSOR OF A DOPAMINERGIC NEUROTOXIN, N-METHYL(R)SALSOLINOL

      Neuroscience letters
    27. MARUYAMA W; NARABAYASHI H; DOSTERT P; NAOI M
      STEREOSPECIFIC OCCURRENCE OF A PARKINSONISM-INDUCING CATECHOL ISOQUINOLINE, N-METHYL(R)SALSOLINOL, IN THE HUMAN INTRAVENTRICULAR FLUID

      Journal of neural transmission
    28. NAOI M; MARUYAMA W; DOSTERT P; HASHIZUME Y
      ANIMAL-MODEL OF PARKINSONS-DISEASE INDUCED BY NATURALLY-OCCURRING ETHYL-6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE

      Biogenic amines
    29. DOSTERT P; LACROIX R; MARUYAMA W; NAOI M; BENEDETTI MS
      EFFECTS OF DOPAMINE-DERIVED ISOQUINOLINES ON HYDROXYL RADICAL FORMATION BY DOPAMINE AUTOXIDATION

      Biogenic amines
    30. FIALIP J; ESCHALIER A; BETOIN F; DURIF F; DOSTERT P; DORDAIN G
      STUDY OF THE ANTINOCICEPTIVE EFFECT OF TETRAHYDROPAPAVEROLINE DERIVATIVES - INTERACTION WITH OPIOIDS

      Life sciences
    31. NAOI M; MARUYAMA W; DOSTERT P; KOHDA J; KAIYA T; HASHIZUME Y; TAKAHASHI T; DENG Y; KAWAI M
      BIOCHEMICAL-MECHANISM OF NEURONAL DEATH - HYPOTHESIS AND FACTS

      Journal of neurochemistry
    32. MARUYAMA W; KASAMATSU T; KOHDA K; ABE T; TOHGI H; DOSTERT P; SOBUE G; HASHIZUME Y; NAOI M
      A PARKINSONISM-INDUCING ENDOGENOUS ISOQUINOLINE, N-METHYL(R)SALSOLINOL - MECHANISM OF CYTOTOXICITY AND APPLICATION AS A PERIPHERAL MARKER

      Journal of neurochemistry
    33. NAOI M; MARUYAMA W; DOSTERT P; HASHIZUME Y; NAKAHARA D; TAKAHASHI T; OTA M
      DOPAMINE-DERIVED ENDOGENOUS THYL-6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE, N-METHYL-(R)-SALSOLINOL, INDUCED PARKINSONISM IN RAT - BIOCHEMICAL, PATHOLOGICAL AND BEHAVIORAL-STUDIES

      Brain research
    34. DENG YL; MARUYAMA W; YAMAMURA H; KAWAI M; DOSTERT P; NAOI M
      MECHANISM OF ENANTIOSEPARATION OF SALSOLINOLS, ENDOGENOUS NEUROTOXINSIN HUMAN BRAIN, WITH ION-PAIR CHROMATOGRAPHY USING BETA-CYCLODEXTRIN AS A MOBILE-PHASE ADDITIVE

      Analytical chemistry
    35. DENG YL; MARUYAMA W; DOSTERT P; TAKAHASHI T; KAWAI M; NAOI M
      DETERMINATION OF THE (R)-ENANTIOMERS AND (S)-ENANTIOMERS OF SALSOLINOL AND N-METHYLSALSOLINOL BY USE OF A CHIRAL HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC COLUMN

      Journal of chromatography B. Biomedical applications
    36. ALLIEVI C; ZUGNONI P; BENEDETTI MS; DOSTERT P
      DETERMINATION OF PLASMA-LEVELS OF EXEMESTANE (FCE-24304), A NEW IRREVERSIBLE AROMATASE INHIBITOR, USING THERMOSPRAY LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY

      Journal of mass spectrometry.
    37. BENEDETTI MS; FRIGERIO E; TOCCHETI P; BRIANCESCHI G; CASTELLI MG; PELLIZZONI C; DOSTERT P
      STEREOSELECTIVE AND SPECIES-DEPENDENT KINETICS OF REBOXETINE IN MOUSEAND RAT

      Chirality
    38. MARUYAMA W; DOSTERT P; MATSUBARA K; NAOI M
      N-METHYL(R)SALSOLINOL PRODUCES HYDROXYL RADICALS - INVOLVEMENT TO NEUROTOXICITY

      Free radical biology & medicine
    39. DOSTERT P; BENEDETTI MS; PERSIANI S; LACROIX R; BOSC M; FIORENTINI F; DEFFOND D; VERNAY D; DORDAIN G
      LACK OF PHARMACOKINETIC INTERACTION BETWEEN THE SELECTIVE DOPAMINE AGONIST CABERGOLINE AND THE MAO-B INHIBITOR SELEGILINE

      Journal of neural transmission. Supplementum
    40. NAOI M; MARUYAMA W; ZHANG JH; TAKAHASHI T; DENG YL; DOSTERT P
      ENZYMATIC OXIDATION OF THE DOPAMINERGIC NEUROTOXIN, HYL-6,7-DIHYDROXY-1,2,3,4,-TETRAHYDROISOQUINOLINE, INTO 1,2(N)-DIMETHYL-6,7-DIHYDROXYISOQUINOLINIUM ION

      Life sciences
    41. MARUYAMA W; DOSTERT P; TAKAHASHI T; NAOI M
      MECHANISM OF CYTOTOXICITY OF 6,7-DIHYDROXY-ISOQUINOLINES ON DOPAMINERGIC-NEURONS IN THE BRAIN - IN-VIVO AND IN-VITRO STUDIES

      Journal of neurochemistry
    42. NAOI M; ZHANG J; MARUYAMA W; DENG Y; DOSTERT P
      CHARACTERISTICS OF ENZYMATIC OXIDATION OF N-METHYLSALSOLINOL IN HUMANBRAIN

      Journal of neurochemistry
    43. TAKAHASHI T; MARUYAMA W; DOSTERT P; DENG Y; NAOI M
      SELECTIVE ACCUMULATION OF 1,2-DIMETHYL-6,7-DIHYDROXYISOQUINOLINIUM ION IN DOPAMINE CELLS

      Journal of neurochemistry
    44. DENG Y; MARUYAMA W; DOSTERT P; KAWAI M; KOHDA K; KAIYA T; NAOI M
      PREDOMINANT OCCURRENCE OF (R)-ENANTIOMERS OF SALSOLINOLS IN HUMAN BRAIN

      Journal of neurochemistry
    45. NAOI M; MARUYAMA W; DOSTERT P
      ANIMAL-MODEL OF PARKINSONS-DISEASE BY NATURALLY-OCCURRING ETHYL-6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE

      Journal of neurochemistry
    46. DOSTERT P; LACROIX R; MARUYAMA W; NAOI M; BENEDETTI MS
      EFFECTS OF DOPAMINE-DERIVED ISOQUINOLINES ON HYDROXYL RADICAL FORMATION BY DOPAMINE AUTOXIDATION

      Journal of neurochemistry
    47. MARUYAMA W; DOSTERT P; NAOI M
      DOPAMINE-DERIVED 1-METHYL-6,7-DIHYDROXYISOQUINOLINES AS HYDROXYL RADICAL PROMOTERS AND SCAVENGERS IN THE RAT-BRAIN - IN-VIVO AND IN-VITRO STUDIES

      Journal of neurochemistry
    48. OBRIEN EM; DOSTERT P; TIPTON KF
      SPECIES-DIFFERENCES IN THE INTERACTIONS OF THE ANTICONVULSANT MILACEMIDE AND SOME ANALOGS WITH MONOAMINE OXIDASE-B

      Biochemical pharmacology
    49. BENEDETTI MS; DOSTERT P
      CONTRIBUTION OF AMINE OXIDASES TO THE METABOLISM OF XENOBIOTICS

      Drug metabolism reviews
    50. NAOI M; MARUYAMA W; DOSTERT P
      BINDING OF 1,2(N)-DIMETHYL-6,7-DIHYDROXY-ISOQUINOLINIUM ION TO MELANIN - EFFECTS OF FERROUS AND FERRIC ION ON THE BINDING

      Neuroscience letters
    51. BENEDETTI MS; THOMASSIN J; TOCCHETTI P; DOSTERT P; KETTLER R; DAPRADA M
      SPECIES-DIFFERENCES IN CHANGES OF HEART MONOAMINE-OXIDASE ACTIVITIES WITH AGE

      Journal of neural transmission. Supplementum
    52. DOSTERT P; CASTELLI MG; CICIONI P; BENEDETTI MS
      REBOXETINE PREVENTS THE TRANYLCYPROMINE-INDUCED INCREASE IN TYRAMINE LEVELS IN RAT-HEART

      Journal of neural transmission. Supplementum
    53. DOSTERT P
      CAN OUR KNOWLEDGE OF MONOAMINE-OXIDASE (MAO) HELP IN THE DESIGN OF BETTER MAO INHIBITORS

      Journal of neural transmission. Supplementum
    54. OBRIEN EM; TIPTON KF; MERONI M; DOSTERT P
      INHIBITION OF MONOAMINE-OXIDASE BY CLORGYLINE ANALOGS

      Journal of neural transmission. Supplementum
    55. TAKAHASHI T; DENG Y; MARUYAMA W; DOSTERT P; KAWAI M; NAOI M
      UPTAKE OF A NEUROTOXIN-CANDIDATE, ETHYL-6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE INTO HUMAN DOPAMINERGIC NEUROBLASTOMA SH-SY5Y CELLS BYDOPAMINE TRANSPORT-SYSTEM

      Journal of neural transmission
    56. NAOI M; MARUYAMA W; SASUGA S; DENG YL; DOSTERT P; OHTA S; TAKAHASHI T
      INHIBITION OF TYPE-A MONOAMINE-OXIDASE BY 2(N)-METHYL-6,7-DIHYDROXYISOQUINOLINIUM IONS

      Neurochemistry international
    57. BENEDETTI MS; DOSTERT P
      INDUCTION AND AUTOINDUCTION PROPERTIES OF RIFAMYCIN DERIVATIVES - A REVIEW OF ANIMAL AND HUMAN STUDIES

      Environmental health perspectives
    58. BENEDETTI MS; MARRARI P; COLOMBO M; CASTELLI MG; ARAND M; OESCH F; DOSTERT P
      THE ANTICONVULSANT FCE-26743 IS A SELECTIVE AND SHORT-ACTING MAO-B INHIBITOR DEVOID OF INDUCING PROPERTIES TOWARDS CYTOCHROME-P450 DEPENDENT TESTOSTERONE HYDROXYLATION IN MICE AND RATS

      Journal of Pharmacy and Pharmacology
    59. THOMAS H; BENEDETTI MS; DOSTERT P; OESCH F
      THE EFFECT OF INDOBUFEN ON THE ACTIVITIES OF SELECTED RAT-LIVER PHASE-I AND PHASE-II DRUG-METABOLIZING-ENZYMES, PEROXISOMAL BETA-OXIDATION AND HEPATIC GLUTATHIONE STATUS

      Journal of Pharmacy and Pharmacology
    60. OBRIEN EM; DOSTERT P; PEVARELLO P; TIPTON KF
      INTERACTIONS OF SOME ANALOGS OF THE ANTICONVULSANT MILACEMIDE WITH MONOAMINE-OXIDASE

      Biochemical pharmacology
    61. BIECK PR; ANTONIN KH; FARGER G; NILSSON EB; SCHMIDT EK; DOSTERT P; BENEDETTI MS; WALDMEIER PC
      CLINICAL-PHARMACOLOGY OF THE NEW COMT INHIBITOR CGP-28014

      Neurochemical research
    62. MARUYAMA W; NAKAHARA D; DOSTERT P; TAKAHASHI A; NAOI M
      NATURALLY-OCCURRING ISOQUINOLINES PERTURB MONOAMINE METABOLISM IN THEBRAIN - STUDIED BY IN-VIVO MICRODIALYSIS

      Journal of neural transmission
    63. BENEDETTI MS; DOSTERT P; MARRARI P; CINI M
      EFFECT OF AGING ON TISSUE-LEVELS OF AMINO-ACIDS INVOLVED IN THE NITRIC-OXIDE PATHWAY IN RAT-BRAIN

      Journal of neural transmission
    64. MINAMI M; MARUYAMA W; DOSTERT P; NAGATSU T; NAOI M
      INHIBITION OF TYPE-A AND TYPE-B MONOAMINE-OXIDASE BY 6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINES AND THEIR N-METHYLATED DERIVATIVES

      Journal of neural transmission
    65. NAOI M; MARUYAMA W; MINAMI M; DOSTERT P; PARVEZ SH; NAGATSU T
      SALSOLINOLS AND OTHER 6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINES AS INHIBITORS OF MONOAMINE-OXIDASE - IN-VIVO AND IN-VITRO STUDY

      Biogenic amines
    66. BATTAGLIA R; BENEDETTI MS; MANTEGANI S; CASTELLI MG; COCCHIARA G; DOSTERT P
      DISPOSITION AND URINARY METABOLIC PATTERN OF CABERGOLINE, A POTENT DOPAMINERGIC AGONIST, IN RAT, MONKEY AND MAN

      Xenobiotica
    67. DOSTERT P; BENEDETTI MS; TOCCHETTI P; COLOMBO M
      STRUCTURE-MODULATED RECOGNITION BY MONOAMINE OXIDASE-B IN A NEW SERIES OF ANTICONVULSANTS

      Journal of neurochemistry
    68. TOCCHETTI P; BENEDETTI MS; COCCHIARA G; DOSTERT P
      IS THE SPECIES-DEPENDENT RESPONSE OF REBOXETINE IN THE ANTIRESERPINE TEST CORRELATED WITH DIFFERENCES IN BRAIN AVAILABILITY

      Journal of neurochemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 03:10:36